When desiccant canister mesh breaks, silica beads escape into pharmaceutical bottles, contaminating the drug product and rendering entire batches unusable.
Mesh breakage is classified as a GMP critical defect. Detection failures lead to non-compliance, regulatory action, and costly product recalls.
A single undetected defect can trigger product recalls affecting thousands of units, damaging brand reputation and incurring massive financial penalties.
Silica desiccant canisters are small containers filled with silica beads placed inside pharmaceutical bottles to absorb moisture. They are essential for oral solid dosage forms (tablets and capsules) to maintain product stability and shelf life. The canister has a protective mesh that keeps the silica beads contained while allowing moisture vapor to pass through.
When the mesh breaks, silica beads contaminate the drug product—a GMP critical event. This triggers immediate batch quarantine, regulatory reporting, product recalls, and potential supply chain disruption. CANIS detects mesh breakage before canisters reach your production line.
CANIS uses multi-camera AI vision inspection to examine each canister at 14,000/hour. High-resolution imaging captures structural details, mesh integrity, labels, and surface defects. AI algorithms instantly classify each canister as pass or reject, with defect images stored for full traceability.
Get comprehensive technical specifications, performance data, and compliance certifications.
Download Brochure PDFCanisters automatically feed into the inspection chamber via vibrating bowl or conveyor system at 14,000/hour.
High-resolution cameras capture images from multiple angles under controlled LED lighting to detect all defect types.
Deep learning algorithms analyze images and instantly classify canisters as pass or reject with confidence scores.
Rejected canisters are pneumatically ejected. All results logged with defect images for complete batch traceability.
Fully compliant with Indian Schedule M pharmaceutical manufacturing guidelines and GMP requirements.
Meets WHO Guidelines for Good Manufacturing Practice Annex 2 inspection requirements.
Role-based access with operator, supervisor, and engineer levels. Full audit trails for regulatory audits.
Batch-to-canister mapping with serial numbers, timestamps, defect images, and operator IDs logged permanently.
Tablets and capsule manufacturers requiring desiccant canister inspection for moisture control.
Canister manufacturers ensuring zero mesh breakage before supply to pharma customers.
Active pharmaceutical ingredient and bulk drug manufacturers using canisters in packaging.
Injectable pharmaceutical manufacturers protecting vials and containers with desiccant canisters.
Two decades of pharmaceutical vision inspection innovation and GMP compliance mastery.
Deep learning detection with >99.8% accuracy for critical defects like mesh breakage.
14,000 canisters/hour inspection speed without compromising quality or reliability.
Schedule M, WHO-GMP, and ISO certified systems with full audit trail documentation.
Dedicated technical support, spare parts availability, and preventive maintenance programs.
Trusted by leading pharma companies, canisters manufacturers, and API producers globally.
Eliminate mesh breakage defects, prevent recalls, and maintain pharmaceutical compliance with CANIS.